Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
1.545
+0.325 (26.64%)
Aug 14, 2025, 2:29 PM - Market open
Cognition Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 10.74 | 25.01 | 29.92 | 41.56 | 54.72 | 5.19 | Upgrade
|
| Cash & Short-Term Investments | 10.74 | 25.01 | 29.92 | 41.56 | 54.72 | 5.19 | Upgrade
|
| Cash Growth | -62.35% | -16.42% | -28.01% | -24.05% | 954.56% | 79.55% | Upgrade
|
| Other Receivables | 6.29 | 2.69 | 1.28 | 3.67 | 2.27 | 1.15 | Upgrade
|
| Receivables | 6.29 | 2.69 | 1.28 | 3.67 | 2.27 | 1.15 | Upgrade
|
| Prepaid Expenses | 1.21 | 1.86 | 3.02 | 2.41 | 2.01 | 0.54 | Upgrade
|
| Other Current Assets | - | - | - | - | - | 0.02 | Upgrade
|
| Total Current Assets | 19.05 | 29.56 | 34.22 | 47.65 | 58.99 | 6.91 | Upgrade
|
| Property, Plant & Equipment | 0.57 | 0.68 | 0.94 | 1.05 | 0.15 | 0.21 | Upgrade
|
| Other Long-Term Assets | - | - | - | 1.73 | - | - | Upgrade
|
| Total Assets | 19.62 | 30.23 | 35.16 | 50.43 | 59.14 | 7.12 | Upgrade
|
| Accounts Payable | 0.77 | 1.98 | 3.7 | 3.22 | 4.17 | 2 | Upgrade
|
| Accrued Expenses | 9.37 | 7.62 | 4.05 | 2.09 | 1.75 | 0.99 | Upgrade
|
| Short-Term Debt | 0.04 | 0.28 | 0.54 | 0.63 | - | - | Upgrade
|
| Current Portion of Leases | 0.2 | 0.19 | 0.17 | 0.15 | - | - | Upgrade
|
| Current Unearned Revenue | 1.98 | 1.07 | 1.7 | 1.7 | 0.75 | - | Upgrade
|
| Other Current Liabilities | - | - | - | - | 1.19 | 0.25 | Upgrade
|
| Total Current Liabilities | 12.36 | 11.14 | 10.17 | 7.8 | 7.86 | 3.25 | Upgrade
|
| Long-Term Debt | - | - | - | - | - | 12.85 | Upgrade
|
| Long-Term Leases | 0.23 | 0.34 | 0.52 | 0.7 | - | - | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | 1.69 | - | - | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | - | 3.83 | Upgrade
|
| Total Liabilities | 12.59 | 11.48 | 10.69 | 10.18 | 7.86 | 19.93 | Upgrade
|
| Common Stock | 0.07 | 0.06 | 0.03 | 0.03 | 0.02 | 0 | Upgrade
|
| Additional Paid-In Capital | 197.34 | 193.85 | 165.83 | 155.82 | 145.45 | 0.22 | Upgrade
|
| Retained Earnings | -190.37 | -175.16 | -141.19 | -115.4 | -94 | -68.22 | Upgrade
|
| Comprehensive Income & Other | - | - | -0.2 | -0.2 | -0.2 | -0.19 | Upgrade
|
| Total Common Equity | 7.03 | 18.75 | 24.47 | 40.25 | 51.27 | -68.18 | Upgrade
|
| Shareholders' Equity | 7.03 | 18.75 | 24.47 | 40.25 | 51.27 | -12.81 | Upgrade
|
| Total Liabilities & Equity | 19.62 | 30.23 | 35.16 | 50.43 | 59.14 | 7.12 | Upgrade
|
| Total Debt | 0.47 | 0.81 | 1.24 | 1.48 | - | 12.85 | Upgrade
|
| Net Cash (Debt) | 10.28 | 24.2 | 28.68 | 40.08 | 54.72 | -7.66 | Upgrade
|
| Net Cash Growth | -62.94% | -15.65% | -28.44% | -26.75% | - | - | Upgrade
|
| Net Cash Per Share | 0.20 | 0.61 | 0.96 | 1.70 | 10.54 | -15.08 | Upgrade
|
| Filing Date Shares Outstanding | 73.47 | 61.97 | 39 | 29.26 | 22.58 | 0.54 | Upgrade
|
| Total Common Shares Outstanding | 64.96 | 59.85 | 32.17 | 28.99 | 22.23 | 0.54 | Upgrade
|
| Working Capital | 6.69 | 18.41 | 24.05 | 39.85 | 51.13 | 3.66 | Upgrade
|
| Book Value Per Share | 0.11 | 0.31 | 0.76 | 1.39 | 2.31 | -126.55 | Upgrade
|
| Tangible Book Value | 7.03 | 18.75 | 24.47 | 40.25 | 51.27 | -68.18 | Upgrade
|
| Tangible Book Value Per Share | 0.11 | 0.31 | 0.76 | 1.39 | 2.31 | -126.55 | Upgrade
|
| Machinery | - | 1.34 | 1.33 | 1.19 | 1.02 | 0.99 | Upgrade
|
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.